India sales increased 15.6% YoY at Rs. 24.2bn on core therapies growth but decreased 10.8% QoQ on account of lower COVID-19 sales. Cipla believes the broader Indian pharmaceuticals market (IPM) can sustain 10-12% annual sales growth without any obs

Bajaj Finance reported AUM growth of 22% YoY and 5% QoQ, 7-12% QoQ growth in consumer durables, personal loans, SME and rural segments, operating costs increased 76% YoY and 48% QoQ led by higher collection costs, increased manpower and branch additi

ITC's 2QFY22 performance was driven by recovery in cigarette volumes and strong performance in the paperboard segment. Overall net sales stood at Rs. 1,27,310mn grew 13.8% YoY and 4.2% QoQ, PAT stood at Rs. 36,972mn, grew 14.4% YoY and 22.7% QoQ, and

Titan's robust margin expansion and earnings growth was driven by stellar sales performance along with the rate of expansion in EBIT margin across all its businesses in Q2FY22. Titan's total revenue excluding bullion segment sales grew by 76

L&T's 2QFY22 operational results were better than estimated, and the margins reported in both the segments were exceptional. Core business performance was affected by COVID challenges and uncertainties, however, margins fared better and wer

ADSEZ's operating performance in 2QFY22 led the EBITDA (ex-forex) to grow 19% YoY to Rs. 22.1bn. Port EBITDA grew +22% YoY with Port margins at 70% vs 70.7% YoY and 70.6% QoQ. Port EBITDA/T stood at Rs. 308 vs. Rs. 306 YoY and INR311 QoQ. In 2QFY22,

Kajaria’s upbeat performance was led by strong volume, capacity utilization at 100% and comfortable transfer of steep gas cost. The company reported a revenue growth of 37% YoY (Rs. 9.7bn) and 20% in H2FY22, volume growth of 25% YoY and 15%

ICICI bank reported robust growth in the recently announced Q2 results, the overall business grew by 19% YoY as the net profit grew to Rs. 55.1bn, NIM grew by 4.0% (up by 11bp QoQ), loan growth stood at 17% YoY and 4% QoQ, NII grew by 25% YoY, fee in

Overall Performance Despite the shocking low underlying volume growth, which stood at ~4%, the underlying domestic consumer business grew at 11% YoY basis. In H1FY22, HUL reported 12% growth in sales, 8.5% growth in EBITDA and 6.2% growth in

ICICI Prudential Life Insurance Company (IPLI) reported strong growth of 43.5% YoY basis in 2QFY22 and 45.4% YoY basis in 1HFY22 in linked savings APE, sales of which were affected in last year due to covid-19. While Non-linked savings (excl. annuity

The quarterly performance of Navin Fluorine stood out in major segments except the CRAMs. For Q2FY22, the company reported a ~5% increase in standalone revenue on YoY basis, EBITDA margin grew by 90bps on QoQ basis, PAT margin marginally grew from 17

Growth of the different verticals Larsen & Toubro Infotech’s key players are its three verticals- BFSI (47% of revenue), Manufacturing (16% of revenue) and Hitech (13% of revenue). Lets talk about the highest revenue earning vertical first.